X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chromans - pharmacology (2785) 2785
science & technology (2477) 2477
life sciences & biomedicine (2415) 2415
animals (2096) 2096
humans (1548) 1548
male (1034) 1034
rats (1002) 1002
antioxidants - pharmacology (839) 839
pharmacology & pharmacy (764) 764
thiazolidinediones (762) 762
troglitazone (685) 685
mice (630) 630
biochemistry & molecular biology (587) 587
thiazoles - pharmacology (579) 579
female (576) 576
cells, cultured (563) 563
thiazolidinediones - pharmacology (522) 522
dose-response relationship, drug (510) 510
hypoglycemic agents - pharmacology (464) 464
chromans - chemistry (396) 396
rats, sprague-dawley (322) 322
antioxidants (309) 309
vitamin e - pharmacology (294) 294
endocrinology & metabolism (279) 279
vitamin e - analogs & derivatives (277) 277
apoptosis - drug effects (274) 274
cell line, tumor (269) 269
rats, wistar (251) 251
in vitro techniques (248) 248
chromans - therapeutic use (237) 237
cell line (236) 236
apoptosis (231) 231
chemistry (230) 230
time factors (230) 230
oxidative stress (229) 229
cell survival - drug effects (227) 227
cell biology (223) 223
lipid peroxidation - drug effects (222) 222
antineoplastic agents - pharmacology (216) 216
toxicology (214) 214
physical sciences (210) 210
reactive oxygen species - metabolism (207) 207
structure-activity relationship (201) 201
chromans - metabolism (193) 193
ligands (188) 188
chemistry, medicinal (187) 187
oncology (186) 186
oxidative stress - drug effects (184) 184
abridged index medicus (182) 182
ppar gamma - metabolism (182) 182
kinetics (180) 180
oxidation-reduction (180) 180
transcription factors - metabolism (179) 179
free radicals (177) 177
rna, messenger - metabolism (176) 176
molecular structure (170) 170
blotting, western (165) 165
chromans - chemical synthesis (165) 165
neurosciences (165) 165
neurosciences & neurology (160) 160
cell proliferation - drug effects (158) 158
free radical scavengers - pharmacology (158) 158
ppar gamma - agonists (157) 157
antioxidant (156) 156
analysis (155) 155
receptors, cytoplasmic and nuclear - metabolism (155) 155
chromans - administration & dosage (154) 154
adult (152) 152
vitamin e (151) 151
lipid peroxidation (145) 145
tumor cells, cultured (145) 145
cardiovascular system & cardiology (144) 144
ascorbic acid - pharmacology (142) 142
sulfonamides - pharmacology (142) 142
insulin resistance (139) 139
liver - drug effects (136) 136
antioxidants - chemistry (133) 133
trolox (131) 131
middle aged (129) 129
enzyme inhibitors - pharmacology (128) 128
prostaglandin d2 - analogs & derivatives (127) 127
piperazines - pharmacology (124) 124
biophysics (123) 123
liver - metabolism (122) 122
prostaglandin d2 - pharmacology (118) 118
cell division - drug effects (116) 116
reverse transcriptase polymerase chain reaction (116) 116
gene expression regulation - drug effects (115) 115
physiology (113) 113
research (113) 113
signal transduction - drug effects (113) 113
chromans (112) 112
transcription factors - genetics (112) 112
disease models, animal (110) 110
reactive oxygen species (110) 110
gene expression (108) 108
physiological aspects (108) 108
thiazoles - therapeutic use (105) 105
glutathione - metabolism (104) 104
guinea pigs (104) 104
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3409) 3409
Japanese (99) 99
Chinese (23) 23
German (17) 17
Russian (15) 15
French (7) 7
Ukrainian (7) 7
Portuguese (6) 6
Polish (4) 4
Spanish (3) 3
Dutch (2) 2
Hungarian (2) 2
Czech (1) 1
Italian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drug metabolism and disposition, ISSN 1521-009X, 08/2007, Volume 35, Issue 8, pp. 1308 - 1314
Hepatic uptake carriers of the organic anion-transporting peptide (OATP) family of solute carriers are more and more recognized as being involved in hepatic... 
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Organic Anion Transporters, Sodium-Independent - genetics | Fatty Acids, Monounsaturated - pharmacology | Cricetulus | Hypolipidemic Agents - metabolism | Hypoglycemic Agents - metabolism | Taurocholic Acid - metabolism | Humans | Hepatocytes - metabolism | Simvastatin - pharmacology | Organic Anion Transporters - metabolism | Chromans - metabolism | Hepatocytes - cytology | Indoles - metabolism | Organic Anion Transporters - genetics | Drug Interactions | Anticholesteremic Agents - metabolism | Chromans - pharmacology | Fatty Acids, Monounsaturated - metabolism | Organic Anion Transporters, Sodium-Independent - metabolism | Indoles - pharmacology | Biological Transport - drug effects | Thiazolidinediones - pharmacology | Hepatocytes - drug effects | Solute Carrier Organic Anion Transporter Family Member 1B3 | CHO Cells | Pravastatin - pharmacology | Recombinant Proteins - metabolism | Taurocholic Acid - pharmacology | Cell Line | Cricetinae | Pravastatin - metabolism | Simvastatin - metabolism | Gemfibrozil - pharmacokinetics | Gemfibrozil - pharmacology | Hypolipidemic Agents - pharmacology | Thiazolidinediones - metabolism | Hypoglycemic Agents - pharmacology | Animals | Estrone - analogs & derivatives | Estrone - metabolism | Protein Binding | Fatty Acids, Monounsaturated - pharmacokinetics | Indoles - pharmacokinetics | Kinetics | Solute Carrier Organic Anion Transporter Family Member 1b1 | Anticholesteremic Agents - pharmacology | Gemfibrozil - metabolism | Index Medicus
Journal Article
Journal Article
Biochemical journal, ISSN 1470-8728, 08/2013, Volume 454, Issue 2, pp. 201 - 208
NAC (N-acetyl-L-cysteine) is commonly used to identify and test ROS (reactive oxygen species) inducers, and to inhibit ROS. In the present study, we identified... 
Catalase | N-acetyl-L-cysteine (NAC) | Proteasome inhibitor | Reactive oxygen species (ROS) | Forkhead box protein M1 (FOXM1) | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Free Radical Scavengers - pharmacology | Oxidants - pharmacology | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Humans | Acetylcysteine - metabolism | Proteasome Inhibitors - chemistry | Proteasome Inhibitors - metabolism | Viral Proteins - metabolism | Antineoplastic Agents, Phytogenic - antagonists & inhibitors | Chromans - metabolism | Proteasome Endopeptidase Complex - drug effects | Chromans - pharmacology | Dioxolanes - pharmacology | Forkhead Transcription Factors - metabolism | Forkhead Transcription Factors - antagonists & inhibitors | Ubiquitinated Proteins - metabolism | Recombinant Proteins - metabolism | Recombinant Proteins - antagonists & inhibitors | Free Radical Scavengers - metabolism | Proteasome Inhibitors - pharmacology | Catalase - genetics | Chromans - antagonists & inhibitors | Hydrogen Peroxide - pharmacology | Viral Proteins - genetics | Oxidants - antagonists & inhibitors | Dioxolanes - antagonists & inhibitors | Forkhead Transcription Factors - genetics | Catalase - metabolism | Reactive Oxygen Species - antagonists & inhibitors | Protein Stability - drug effects | Acetylcysteine - pharmacology | Cell Line, Tumor | Cytomegalovirus - enzymology | Proteasome Endopeptidase Complex - metabolism | Antineoplastic Agents, Phytogenic - pharmacology | Forkhead Box Protein M1 | Hydrogen Peroxide - antagonists & inhibitors | Index Medicus | N-acetyl-l-cysteine (NAC) | proteasome inhibitor | reactive oxygen species (ROS) | catalase
Journal Article
Pflügers Archiv, ISSN 1432-2013, 08/2014, Volume 467, Issue 7, pp. 1431 - 1443
Journal Article
Journal Article
Atherosclerosis, ISSN 0021-9150, 2009, Volume 207, Issue 2, pp. 405 - 411
Abstract Introduction Hyperglycemia is a risk factor for cardiovascular complications in diabetic state. Hyperglycemia-induced oxidative stress up-regulates... 
Cardiovascular | Hyperglycemia | Carbon monoxide | AMP-activated protein kinase | Endothelial cells | PPAR-gamma | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Enzyme Activators - pharmacology | Tyrosine - pharmacology | AMP-Activated Protein Kinases - metabolism | PPAR gamma - drug effects | Humans | Benzophenones - pharmacology | Carbon Monoxide - metabolism | PPAR gamma - metabolism | Tyrosine - analogs & derivatives | Aminoimidazole Carboxamide - pharmacology | Dose-Response Relationship, Drug | Ribonucleotides - pharmacology | Transfection | Chromans - pharmacology | Time Factors | Thiazolidinediones - pharmacology | Pyrazoles - pharmacology | Anti-Inflammatory Agents - pharmacology | AMP-Activated Protein Kinases - antagonists & inhibitors | Cells, Cultured | Pyrimidines - pharmacology | Cell Adhesion - drug effects | Hypoglycemic Agents - pharmacology | Intercellular Adhesion Molecule-1 - metabolism | Aminoimidazole Carboxamide - analogs & derivatives | Organometallic Compounds - metabolism | Signal Transduction - drug effects | Anilides - pharmacology | Glucose - metabolism | Protein Kinase Inhibitors - pharmacology | Enzyme Activation | Endothelial Cells - enzymology | AMP-Activated Protein Kinases - genetics | Organometallic Compounds - pharmacology | Troglitazone | Endothelial Cells - drug effects | Index Medicus
Journal Article
Free radical biology & medicine, ISSN 0891-5849, 2003, Volume 35, Issue 11, pp. 1500 - 1514
Journal Article
PloS one, ISSN 1932-6203, 01/2014, Volume 9, Issue 1, pp. e84248 - e84248
Since the serendipitous discovery of cisplatin, platinum-based drugs have become well-established antitumor agents, despite the fact that their clinical use is... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Free Radical Scavengers - pharmacology | Apoptosis - drug effects | Humans | Antineoplastic Agents - administration & dosage | Molecular Targeted Therapy | Peptidomimetics - administration & dosage | Thiocarbamates - pharmacology | Chromans - pharmacology | Organogold Compounds - administration & dosage | Drug Design | Female | Antineoplastic Agents - pharmacology | Molecular Structure | Drug Evaluation, Preclinical | Organogold Compounds - chemistry | Disease Models, Animal | Peptidomimetics - pharmacology | Thiocarbamates - administration & dosage | Proteasome Inhibitors - pharmacology | Peptidomimetics - chemistry | Cisplatin - pharmacology | Thiocarbamates - chemistry | Antineoplastic Agents - chemistry | Breast Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Animals | Organogold Compounds - pharmacology | Tumor Burden - drug effects | Breast Neoplasms - pathology | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Proteasome Endopeptidase Complex - metabolism | Chemotherapy | Peptides | Health aspects | Cancer | Drugs | Delivery systems | Clinical trials | Homeostasis | Oncology | Biochemistry | Metastasis | Kinases | Cancer therapies | Anticancer properties | Proteins | Antitumor agents | Platinum | Xenografts | Cell cycle | Inhibition | Sulfur | Gold | Enzymes | Medical research | Departments | Breast cancer | Pharmacology | Shrinkage | Cisplatin | Medicine | Pathology | Chemistry | Side effects | Peptidomimetics | Ligands | Drug discovery | Prostate cancer | Apoptosis | Index Medicus
Journal Article